@jhrheumatology Michelle Petri MD MPH: thrombosis risk composite score = Low C3 + dRVVT + Platelet C4d. Abst#1513. PltC4d associated with proteinuria, venous/arterial thrombosis. #ACR20 @RheumNow https://t.co/OdAjul5Usg
Eric Dein @ejdein1 ( View Tweet)
@andreafava @jhrheumatology shows class switch is common in lupus nephritis biopsy, chronicity scores are critical. Shows value of need for liquid biopsy @rheumnow #ACR20 Abst#1512 https://t.co/M0DWmTLP29
Eric Dein @ejdein1 ( View Tweet)
Abs1467 has highlighted the importance of presenteeism and work cessation in patients with rheumatic diseases.
How can we best address this for our patients?
#ACR20 @RheumNow
Mrinalini Dey @DrMiniDey ( View Tweet)
When discussing pregnancy outcomes with your axSpA patients, do you address potential outcomes related to disease in addition to medication concerns? #ACR20 @RheumNow
Dr. Rachel Tate @uptoTate ( View Tweet)
Test your #ACR20 IQ--where do you stack up on the leaderboard?
https://t.co/7J1SoJQARa https://t.co/PUbaLUhEg6
Links:
Dr. John Cush @RheumNow ( View Tweet)
Despite 30% decrease in mortality over the past 2 decades, the mortality gap remains in psoriasis and #PsA. #ACR20 Abstract #1476 by @Keith_Colaco. @NPF @WCRInstitute @researchuoft @RheumNow @rheum_cat https://t.co/CXTELMJh8P
Lihi Eder @lihi_eder ( View Tweet)
European Rheum Consortium (SHARE) recommendations for Rx of systemic JIA: 1) Systemic JIA - AOSD; 2) STEROIDs, 3) IL-1 inhibitors; 4) TCZ, 5) MTX & TNFi mainly for arthritis. Should be aware of risk for MAS and ILD #ACR20 Abstr#1148 https://t.co/mgZvLKNljs
Dr. John Cush @RheumNow ( View Tweet)
Obesity, high-positive CRP, poor functional status, and a smoking threshold of 30 pack-years as novel predictors of RA-ILD @RheumNow #ACR20 Abstr#1198 #ACRbest
Dr. Antoni Chan @synovialjoints ( View Tweet)
